
USD
( +0.00%
At Close (As of Jan 1, 1970)
$6.55B
Market Cap
-
P/E Ratio
-4.92
EPS
$99.94
52 Week High
$55.53
52 Week Low
HEALTHCARE
Sector
| Field | Value (USD) |
|---|---|
| Gross Profit | - |
| Total Revenue | $0 |
| Cost Of Revenue | - |
| Costof Goods And Services Sold | - |
| Operating Income | -$280M |
| Selling General And Administrative | $63M |
| Research And Development | $218M |
| Operating Expenses | $280M |
| Investment Income Net | - |
| Net Interest Income | $38M |
| Interest Income | $38M |
| Interest Expense | $38M |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $280M |
| Income Before Tax | -$260M |
| Income Tax Expense | $764K |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$261M |
| Comprehensive Income Net Of Tax | - |
| Ebit | -$222M |
| Ebitda | -$280M |
| Net Income | -$261M |
| Field | Value (USD) |
|---|---|
| Total Assets | $1.1B |
| Total Current Assets | $1.1B |
| Cash And Cash Equivalents At Carrying Value | $146M |
| Cash And Short Term Investments | $146M |
| Inventory | - |
| Current Net Receivables | - |
| Total Non Current Assets | $9.3M |
| Property Plant Equipment | - |
| Accumulated Depreciation Amortization Ppe | - |
| Intangible Assets | - |
| Intangible Assets Excluding Goodwill | - |
| Goodwill | - |
| Investments | - |
| Long Term Investments | - |
| Short Term Investments | $973M |
| Other Current Assets | $14M |
| Other Non Current Assets | - |
| Total Liabilities | $72M |
| Total Current Liabilities | $54M |
| Current Accounts Payable | $5.2M |
| Deferred Revenue | - |
| Current Debt | - |
| Short Term Debt | - |
| Total Non Current Liabilities | $18M |
| Capital Lease Obligations | - |
| Long Term Debt | - |
| Current Long Term Debt | - |
| Long Term Debt Noncurrent | - |
| Short Long Term Debt Total | - |
| Other Current Liabilities | $49M |
| Other Non Current Liabilities | - |
| Total Shareholder Equity | $1.1B |
| Treasury Stock | - |
| Retained Earnings | -$547M |
| Common Stock | $8K |
| Common Stock Shares Outstanding | $66M |
| Field | Value (USD) |
|---|---|
| Operating Cashflow | -$185M |
| Payments For Operating Activities | - |
| Proceeds From Operating Activities | - |
| Change In Operating Liabilities | - |
| Change In Operating Assets | - |
| Depreciation Depletion And Amortization | - |
| Capital Expenditures | $0 |
| Change In Receivables | - |
| Change In Inventory | - |
| Profit Loss | - |
| Cashflow From Investment | -$574M |
| Cashflow From Financing | $569M |
| Proceeds From Repayments Of Short Term Debt | - |
| Payments For Repurchase Of Common Stock | - |
| Payments For Repurchase Of Equity | - |
| Payments For Repurchase Of Preferred Stock | - |
| Dividend Payout | - |
| Dividend Payout Common Stock | - |
| Dividend Payout Preferred Stock | - |
| Proceeds From Issuance Of Common Stock | - |
| Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
| Proceeds From Issuance Of Preferred Stock | - |
| Proceeds From Repurchase Of Equity | - |
| Proceeds From Sale Of Treasury Stock | - |
| Change In Cash And Cash Equivalents | - |
| Change In Exchange Rate | - |
| Net Income | -$261M |
| Field | Value (USD) |
|---|---|
| Gross Profit | - |
| Total Revenue | $0 |
| Cost Of Revenue | - |
| Costof Goods And Services Sold | - |
| Operating Income | -$280M |
| Selling General And Administrative | $63M |
| Research And Development | $218M |
| Operating Expenses | $280M |
| Investment Income Net | - |
| Net Interest Income | $38M |
| Interest Income | $38M |
| Interest Expense | $38M |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $280M |
| Income Before Tax | -$260M |
| Income Tax Expense | $764K |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$261M |
| Comprehensive Income Net Of Tax | - |
| Ebit | -$222M |
| Ebitda | -$280M |
| Net Income | -$261M |
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
None